Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec;172(24):5729-43.
doi: 10.1111/bph.13347.

The Concise Guide to PHARMACOLOGY 2015/16: Overview

Collaborators, Affiliations

The Concise Guide to PHARMACOLOGY 2015/16: Overview

Stephen Ph Alexander et al. Br J Pharmacol. 2015 Dec.

Abstract

The Concise Guide to PHARMACOLOGY 2015/16 provides concise overviews of the key properties of over 1750 human drug targets with their pharmacology, plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. The full contents can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.13347/full. This compilation of the major pharmacological targets is divided into eight areas of focus: G protein-coupled receptors, ligand-gated ion channels, voltage-gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The Concise Guide is published in landscape format in order to facilitate comparison of related targets. It is a condensed version of material contemporary to late 2015, which is presented in greater detail and constantly updated on the website www.guidetopharmacology.org, superseding data presented in the previous Guides to Receptors & Channels and the Concise Guide to PHARMACOLOGY 2013/14. It is produced in conjunction with NC-IUPHAR and provides the official IUPHAR classification and nomenclature for human drug targets, where appropriate. It consolidates information previously curated and displayed separately in IUPHAR-DB and GRAC and provides a permanent, citable, point-in-time record that will survive database updates.

PubMed Disclaimer

Similar articles

  • The Concise Guide to PHARMACOLOGY 2015/16: Enzymes.
    Alexander SP, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators. Alexander SP, et al. Br J Pharmacol. 2015 Dec;172(24):6024-109. doi: 10.1111/bph.13354. Br J Pharmacol. 2015. PMID: 26650445 Free PMC article.
  • The Concise Guide to PHARMACOLOGY 2015/16: Other ion channels.
    Alexander SP, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators. Alexander SP, et al. Br J Pharmacol. 2015 Dec;172(24):5942-55. doi: 10.1111/bph.13351. Br J Pharmacol. 2015. PMID: 26650442 Free PMC article.
  • The Concise Guide to PHARMACOLOGY 2015/16: Ligand-gated ion channels.
    Alexander SP, Peters JA, Kelly E, Marrion N, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators. Alexander SP, et al. Br J Pharmacol. 2015 Dec;172(24):5870-903. doi: 10.1111/bph.13350. Br J Pharmacol. 2015. PMID: 26650440 Free PMC article.
  • The Concise Guide to PHARMACOLOGY 2023/24: Introduction and Other Protein Targets.
    Alexander SPH, Kelly E, Mathie AA, Peters JA, Veale EL, Armstrong JF, Buneman OP, Faccenda E, Harding SD, Spedding M, Cidlowski JA, Fabbro D, Davenport AP, Striessnig J, Davies JA, Ahlers-Dannen KE, Alqinyah M, Arumugam TV, Bodle C, Dagner JB, Chakravarti B, Choudhuri SP, Druey KM, Fisher RA, Gerber KJ, Hepler JR, Hooks SB, Kantheti HS, Karaj B, Layeghi-Ghalehsoukhteh S, Lee JK, Luo Z, Martemyanov K, Mascarenhas LD, McNabb H, Montañez-Miranda C, Ogujiofor O, Phan H, Roman DL, Shaw V, Sjogren B, Sobey C, Spicer MM, Squires KE, Sutton L, Wendimu M, Wilkie T, Xie K, Zhang Q, Zolghadri Y. Alexander SPH, et al. Br J Pharmacol. 2023 Oct;180 Suppl 2:S1-S22. doi: 10.1111/bph.16176. Br J Pharmacol. 2023. PMID: 38123153 Review.
  • The Concise Guide to PHARMACOLOGY 2023/24: Enzymes.
    Alexander SPH, Fabbro D, Kelly E, Mathie AA, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Davies JA, Annett S, Boison D, Burns KE, Dessauer C, Gertsch J, Helsby NA, Izzo AA, Ostrom R, Papapetropoulos A, Pyne NJ, Pyne S, Robson T, Seifert R, Stasch JP, Szabo C, van der Stelt M, van der Vliet A, Watts V, Wong SS. Alexander SPH, et al. Br J Pharmacol. 2023 Oct;180 Suppl 2:S289-S373. doi: 10.1111/bph.16181. Br J Pharmacol. 2023. PMID: 38123154 Review.

Cited by

References

    1. Andrade C (1952) [12978172]
    1. Alduaij W et al (2011) [21378274]
    1. Baca M et al (1998) Anti‐vegf antibodies. Patent number: WO1998045331. Assignee: Genentech Inc,. Priority date: 07/04/1997. Publication date: 15/10/1998.
    1. Balendiran GK et al (2000) [10854433]
    1. Berardi F et al (1996) [8568804]

Publication types